Since 1989, Warburg Pincus has invested more than $1 billion in the medical devices industry. WIth equity in more than 20 companies across the entire medical devices sector, the team focuses on investments in:

• Diabetes
• Interventional Cardiology
• Interventional Neurology
• Orthopedics
• Urology/Gynecology

Our success is based on a differentiated approach to investing that helps create sustainable value in partnership with entrepreneurs and companies. This approach has four characteristics:

Long-term Investing: We know that it takes time to build a world class medical devices company. Our long-term investment horizon is consistent with the time required to develop and launch new medical devices. The average investment period of five to nine years is longer than most other firms in the industry. We also believe that most of the value in our companies is created after the initial investment -- when we are able to work closely with our entrepreneurs and management teams.

Total Financing Capability: Warburg Pincus is currently investing from its $8 billion fund, one of the largest private equity funds in the world. We offer financing from the initial investment through to profitability, which allows management to concentrate on running and growing a business without the distraction of constant fundraising.

Industry Experience and Relationships: We contribute more than capital when we invest in a company. During our 16 years investing in the industry, we have developed deep domain expertise and an unparalleled network of device industry executives and advisors.

Investment Across All Stages: Unlike most other private equity firms, we are comfortable working with both entrepreneurs and mature companies. The firm has developed a unique combination of industry expertise and financial sophistication that results in successful investments in companies at any point in their lifecycles -- from early-stage ventures to later-stage growth capital, up through leveraged buy-outs.